Compounding experts review the results of the seventh annual Critical Point USP 797 Compliance Study. Are we as safe as an industry as we should be?
Ever since a series of widely reported sterile compounding incidents involving patient harm and death, hospital pharmacies have been under much closer scrutiny by regulatory and licensing agencies for compliance with USP 797, but has the industry response been as thorough as it needs to be?
Join us for this webinar unveiling the results of the seventh annual Critical Point USP 797 Compliance Study. Kate Douglass, MS, RN, CRNI and Eric Kastango, RPh, MBA, unveil the data, explore how it compares to previous years, and explain what it means for sterile compounding safety going forward.
